The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Active monitoring of 12760 clozapine recipients in the UK and Ireland: Beyond pharmacovigilance
Abstract
Background: People prescribed clozapine for treatment-resistant schizophrenia have mandatory haematological monitoring through a case register for identifying reversible neutropenia. Aims: To quantify risk factors for agranulocytosis in subjects receiving clozapine. Method: Data from 12 760 subjects registered to receive clozapine from January 1990 to April 1997 were analysed. Risk factors for agranulocytosis were quantified using a Cox proportional-hazards regression analysis. Results: The risk for agranulocytosis in Asian subjects was 2.4 times that in Caucasians (P=0.03). There was an age-related increase in risk of 53% per decade (P=0.0001). Conclusions: The case register yielded valuable information for guiding research into the causes of the haematological reactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Excess mortality of mental disorder
Harris, C., & Barraclough, B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.1.11 · Cited by 1,881
Clozapine-induced agranulocytosis. incidence and risk factors in the united states
Alvir, J. M. J., Lieberman, J. A., Safferman, A. Z., Schwimmer, J. L., & Schaaf, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307153290303 · Cited by 967
Statistical Methods in Cancer Research, Volume II: The Design and Analysis of Cohort Studies.
Cornell, R. G., Breslow, N. E., & Day, N. E. (1992) · Journal of the American Statistical Association · doi:10.2307/2290308 · Cited by 691
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.183 · Cited by 436
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
Mortality in a Cohort of Patients with Schizophrenia: A Record Linkage Study*
Newman, S. C., & Bland, R. C. (1991) · The Canadian Journal of Psychiatry · doi:10.1177/070674379103600401 · Cited by 371
Neutropenia and Agranulocytosis in Patients Receiving Clozapine in the UK and Ireland
Atkin, K., Kendall, F., Gould, D., Freeman, H., Lieberman, J., & O'Sullivan, D. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.483 · Cited by 293
Self-citationHelgason, L. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb06486.x · Cited by 196
Mortality in DSM-IIIR schizophrenia
Black, D. W., & Fisher, R. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90040-c · Cited by 85
A 15‐year follow‐up study of Chinese schizophrenic patients
Tsoi, W. F., & Wong, K. E. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb03132.x · Cited by 50
Anderson, C., Connelly, J., Johnstone, E. C., & Owens, D. G. C. (1991) · The British Journal of Psychiatry · doi:10.1192/s0007125000296335 · Cited by 20
Cited by
Meltzer, H. Y. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.1.82 · Cited by 1,393
Management of common adverse effects of antipsychotic medications
Stroup, T. S., & Gray, N. (2018) · World Psychiatry · doi:10.1002/wps.20567 · Cited by 572
Adverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications
Haddad, P. M., & Sharma, S. G. (2007) · CNS Drugs · doi:10.2165/00023210-200721110-00004 · Cited by 456
Suicide risk in schizophrenia: learning from the past to change the future
Pompili, M., Amador, X. F., Girardi, P., Harkavy-Friedman, J., Harrow, M., Kaplan, K., Krausz, M., Lester, D., Meltzer, H. Y., Modestin, J., et al. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-10 · Cited by 358
Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research
Arranz, M. J., & de Leon, J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002009 · Cited by 351
Metadata
- Authors
- Munro, J., O'Sullivan, D., Andrews, C., Arana, A., Mortimer, A., & Kerwin, R.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1999-12
- Volume
- 175
- Issue
- 6
- Pages
- 576-580
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2060442024
- Cited by
- 285
- References
- 12
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.